Search

161. CMS’s encounter data lack essential information that Medicare Advantage organizations have the ability to collect

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, August 2020

Subject(s):

Data Management -- legislation & jurisprudence
Fraud -- prevention & control
Government Regulation
Medicare Part C -- organization & administration
Records -- statistics & numerical data
United States
United States. Department of Health and Human Services

162. COVID-19 Provider Relief Fund: HRSA continues to recover remaining payments due from providers : report to congressional committees

Publication:

Washington, DC : United States Government Accountability Office, September 2023

Subject(s):

COVID-19
Disaster Planning -- economics
Disaster Planning -- organization & administration
Fraud -- prevention & control
Government Regulation
Health Personnel -- economics
Legislation, Medical
United States
United States. Health Resources and Services Administration

163. COVID-19 antivirals utilization: geographic and demographic patterns of treatment in 2022

Author(s):

Murphy, Stephen J. (Stephen James), author
Samson, Lok Wong, author
Sommers, Benjamin D., author

Publication:

Washington, D.C. : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, December 23, 2022

Subject(s):

Antiviral Agents -- therapeutic use
COVID-19 Drug Treatment
Drug Utilization -- statistics & numerical data
State Government
United States

164. COVID-19 cases and deaths, metropolitan and nonmetropolitan counties over time: (update)

Author(s):

Ullrich, Fred, author
Mueller, Keith, author

Publication:

Iowa City, IA : Rural Policy Research Institute, February 2022

Subject(s):

COVID-19 -- epidemiology
COVID-19 -- mortality
Rural Population -- statistics & numerical data
Urban Population -- statistics & numerical data
United States

165. COVID-19 container closure system and component changes: glass vials and stoppers

Publication:

[Silver Spring, MD] : Center for Drug Evaluation and Research, March 2021

Subject(s):

Drug Packaging
Glass
COVID-19
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

166. COVID-19 contracting: Indian Health Service used flexibilities to meet increased medical supply needs : report to congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, October 2021

Subject(s):

American Indian or Alaska Native -- statistics & numerical data
COVID-19 -- ethnology
Equipment and Supplies -- supply & distribution
Government Regulation
United States
United States. Indian Health Service

167. COVID-19 hospitalizations in Pennsylvania: March to June 2020

Publication:

Harrisburg, PA : Pennsylvania Health Care Cost Containment Council, July 2021

Subject(s):

COVID-19 -- epidemiology
Hospitalization -- statistics & numerical data
Hospitalization -- trends
Pennsylvania
United States

168. COVID-19 in nursing homes: CMS needs to continue to strengthen oversight of infection prevention and control : report to congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, September 2022

Subject(s):

COVID-19
Government Regulation
Infection Control -- legislation & jurisprudence
Legislation, Medical
Nursing Homes -- standards
United States
Centers for Medicare & Medicaid Services (U.S.)

169. COVID-19 in nursing homes: Experts identified actions aimed at improving infection prevention and control : report to congressional addressees

Publication:

Washington, DC : United States Government Accountability Office, March 2023

Subject(s):

COVID-19 -- prevention & control
Cross Infection -- prevention & control
Hand Hygiene -- legislation & jurisprudence
Government Regulation
Legislation, Medical
Nursing Homes -- legislation & jurisprudence
United States

170. COVID-19 in nursing homes: HHS has taken steps in response to pandemic, but several GAO recommendations have not been implemented : testimony before the Committee on Finance, U.S. Senate

Publication:

Washington, DC : United States Government Accountability Office, March 17, 2021

Subject(s):

COVID-19 -- economics
Government Regulation
Nursing Homes -- trends
United States